CD274 and adenocarcinoma: In the entire cohort AB, most patients had an ECOG PS of 0/1 (87%), PD-L1-positive tumors (81% with TPS at least 1%), and adenocarcinomas (73%), In the same cohort (AB), the ORR was 35%, the DCR 61%, the median TOT 5.8 months, and the median OS 18.6 months (Table 1).